- Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.
Basal insulin such as Levemir is a type of long-acting insulin injected once or twice a day as opposed to rapid, short, or intermediate-acting insulin. It is often used by people with Type 1 diabetes and sometimes by people with Type 2.Novo, which overtook LVMH as Europe's most valuable listed company this year, posted record operating profit for the third quarter, with sales of its obesity drug Wegovy reaching $1.36 billion, up 28% from the previous quarter.
Thousands of people are reportedly lining up to have a portion of their skull removed and one of Elon Musk's brain chips implanted
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Factbox-How Huawei plans to rival Nvidia in the AI chip businessU.S. curbs on the sales of advanced artificial chips by Nvidia to China are creating an opening for Huawei to win market share, with sources saying it won a ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Emerging market currencies to claw back ground in 2024 as dollar fades: Reuters pollEmerging market currencies will take well into next year to start making noticeable gains against a retreating U.S. dollar, despite a growing view the...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Embraer hopeful E2 jets can break into U.S. market, CEO saysBrazilian planemaker Embraer has been trying to sell U.S. carriers on the merits of its E195-E2 jet as a 'small narrow-body', even as demand in its No.1...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »